Moreover, it has been shown, using chemoattractant protein-1 (MCP1)-mediated bone cancer pain model, that there is a significant dependence between PI3K/Akt and microglia activation (Jin et al., 2015). This evidence concerns the gene CCL2 and bone neoplasm.